[
  {
    "entry_id": "map07024",
    "name": "HMG-CoA reductase inhibitors",
    "description": "HMG-CoA reductase inhibitors, also known as statins, are a class of cholesterol lowering drugs that target HMG-CoA reductase in the mevalonate pathway. In 1971 Akira Endo and his team working for the Japanese pharmaceutical company Sankyo started a project to search for microbial metabolites that would inhibit HMG-CoA reductase, the rate-limiting enzyme in the cholesterol biosynthesis, hoping that certain microorganisms would produce such inhibitors as a weapon against other microbes. After screening 6,000 microbial strains mevastatin was discovered from Penicillium citrinum, but the clinical trial of mevastatin was not completed because of its toxicity. The first successful statin was lovastatin isolated from Aspergillus terreus by Merck, which had repeated Sankyo's approach to microbial screening. Following the first generation statins that are based on natural products, the second and the third generation statins were developed using chemical synthesis.",
    "classes": [

    ],
    "diseases": {
    },
    "dblinks": {
    },
    "pathways": {
      "map07024": "HMG-CoA reductase inhibitors"
    },
    "orthologs": {
    },
    "references": [
      {
        "authors": [
          "Sano T",
          "Naito T",
          "Kubo T (eds)."
        ],
        "title": "[Medicinal Chemistry, an Introduction (7th ed)] (In Japanese)",
        "journal": "Nankodo",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "2002",
        "pubmed": "",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": [
          "(Japanese)"
        ],
        "affiliations": [

        ]
      },
      {
        "authors": [
          "Fukai S."
        ],
        "title": "[New Drugs Today (6th ed)] (In Japanese)",
        "journal": "Jiho",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "1995",
        "pubmed": "",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": [
          "(Japanese)"
        ],
        "affiliations": [

        ]
      },
      {
        "authors": [
          "Walter S."
        ],
        "title": "Drug Discovery: A History",
        "journal": "Wiley",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "2005",
        "pubmed": "",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": null,
        "affiliations": [

        ]
      },
      {
        "authors": [
          "Japan Pharmaceutical Association (ed)."
        ],
        "title": "[Face of Medecine: Structure Activity Relationship] (In Japanese)",
        "journal": "Yakuji Nippo",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "1999",
        "pubmed": "",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": [
          "(Japanese)"
        ],
        "affiliations": [

        ]
      },
      {
        "authors": [
          "Noguchi S",
          "Hibino S (eds)."
        ],
        "title": "[Medicinal Chemistry: Bridge Between Biology (3rd ed)] (In Japanese)",
        "journal": "Hirokawa",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "2002",
        "pubmed": "",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": [
          "(Japanese)"
        ],
        "affiliations": [

        ]
      },
      {
        "authors": [
          "Teramoto T (ed)."
        ],
        "title": "[Statins Q & A] (In Japanese)",
        "journal": "Iyaku journal",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "2001",
        "pubmed": "",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": [
          "(Japanese)"
        ],
        "affiliations": [

        ]
      },
      {
        "authors": [
          "Takamisawa I",
          "Shiba M."
        ],
        "title": "[Structure, activity and metabolism of statins.] (In Japanese)",
        "journal": "Chiryogaku",
        "volume": "36(5)",
        "issue": "",
        "pages": "35-40",
        "year": "2002",
        "pubmed": "",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": [
          "(Japanese)"
        ],
        "affiliations": [

        ]
      },
      {
        "authors": [
          "Furberg CD"
        ],
        "title": "Natural statins and stroke risk.",
        "journal": "Circulation 99:185-8 (1999) DOI:10.1161/01.CIR.99.2.185",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "",
        "pubmed": "9892578",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": null,
        "affiliations": [

        ]
      },
      {
        "authors": [
          "Veillard NR",
          "Mach F."
        ],
        "title": "Statins: the new aspirin?",
        "journal": "Cell Mol Life Sci 59:1771-86 (2002) DOI:10.1007/PL00012505",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "",
        "pubmed": "12530513",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": null,
        "affiliations": [

        ]
      },
      {
        "authors": [
          "Endo A."
        ],
        "title": "The discovery and development of HMG-CoA reductase inhibitors. 1992.",
        "journal": "Atheroscler Suppl 5:67-80 (2004) DOI:10.1016/j.atherosclerosissup.2004.08.026",
        "volume": "",
        "issue": "",
        "pages": "",
        "year": "",
        "pubmed": "15531278",
        "medline": "",
        "doi": null,
        "abstract": "",
        "url": null,
        "mesh": [

        ],
        "embl_gb_record_number": null,
        "sequence_position": null,
        "comments": null,
        "affiliations": [

        ]
      }
    ],
    "modules": {
    },
    "organism": "",
    "genes": {
    },
    "enzymes": [

    ],
    "reactions": {
    },
    "compounds": {
      "C00356": "(S)-3-Hydroxy-3-methylglutaryl-CoA",
      "C13334": "Pitavastatin",
      "C13963": "Mevastatin",
      "D00359": "Lovastatin (USP/INN)",
      "D00434": "Simvastatin (JP17/USP/INN)",
      "D00887": "Atorvastatin calcium anhydorous",
      "D00889": "Cerivastatin sodium (JAN/USAN)",
      "D00892": "Fluvastatin sodium (JAN/USAN)",
      "D00893": "Pravastatin sodium (JP17/USAN)",
      "D01862": "Pitavastatin calcium (JAN)",
      "D01915": "Rosuvastatin calcium (JAN/USAN)",
      "D02258": "Atorvastatin calcium (USP)",
      "D07474": "Atorvastatin (INN)",
      "D07661": "Cerivastatin (INN)",
      "D07983": "Fluvastatin (INN)",
      "D08410": "Pravastatin (INN)",
      "D08492": "Rosuvastatin (INN)"
    },
    "rel_pathways": {
    },
    "ko_pathway": ""
  }
]